Drug Profile
Mesenchymal stem cell therapy - Translational Biosciences
Alternative Names: Mesenchymal Trophic Factor; Mesenchymal Trophic Factor - Translational Biosciences; Trophic factors from umbilical cord mesenchymal stem cells; Trophic factors from umbilical cord mesenchymal stem cells - Translational BiosciencesLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Translational Biosciences
- Class Antirheumatics; Mesenchymal stem cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Multiple sclerosis; Osteoarthritis
Most Recent Events
- 26 Sep 2019 Discontinued - Phase-I/II for Multiple sclerosis in Panama (IV)
- 26 Sep 2019 Discontinued - Phase-I/II for Osteoarthritis in Panama (Intra-arterial)
- 26 Sep 2019 Discontinued - Phase-I/II for Osteoarthritis in Panama (SC)